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The endothelium forms the lining of tunica intima, a single cell layer at the interface
between the blood and the extravascular fluid spaces. Not many years ago ther endothelium
was considered a simple structural barrier that merely modulated permeation through the vessel
wall by providing pores of appropriate size. Largely as a result of progress in tissue culture
technology, we now know that endothelial cells accomplish a long list of metabolic functions.
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Глубокоуважаемые коллеги!
24'25 мая 2012 года в г. Одессе на базе УкрНИИ медицины транспорта состоится
научно3практическая конференция “XI3е чтения им. В.В.Подвысоцкого”. Представляем Ва3
шему вниманию материалы исследований участников конференции.
Теоретические статьи Theoretical Articles
In a number of diseases, endothelial
dysfunction is associated with the
subendothelial accumulation of blood3borne
materials [1]. For example, the accretion of
lipid beneath the endothelium in
atherosclerotic lession reflects the failure of
the endothelium to serve as an effective
barrier between tissue and plasma. Thus, a
modern view of endothelium holds that the
metabolic and endocrine functions of its cells
play a critical role in disease. The normal
endothelium maintains a continuous release
of nitric oxide (NO), which is formed from L3
arginine through the action of the enzyme
nitric oxide synthase [2, 3]. The production of
NO can be stimulated by a variety of
endothelial agonists, including acetylcholine,
bradykinin, histamine and thrombin. Shear
stress resulting from an increase in blood flow
or blood pressure also stimulates NO
production and vessel relaxation. NO also
inhibit platelet aggregation and secretion of
platelet contents, many of which cause
vasoconstriction. The fact, that nitric oxide is
released into the vessel lumen (to inactive
platelets) and away from the lumen (to relax
smooth muscle) suggests that it protects
against both thrombosis and vasoconstriction
[3]. The major cause of insuficient coronary
flow leading to a heart attack is the presence
of atherosclerosis in these vessels.
Cardiovascular diseases (CVD) are the major
causes of mortality in persons with diabetes,
and many factors, including hypertension,
contribute to this high prevalence of CVD.
Endothelial dysfunctions leads to a variety
CVD with platelet hyperaggregability,
coagulation abnormalities, hypertension or
diabetes. They are as important risk factors
for life3threatening complications such as
coronary artery diseases, atherothrombosis,
heart failure and stroke, end3stage renal
disease, diseases associated with serious
cardiovascular and renal co3morbidity and
with substantial a lot of social and economic
costs [4].
Introduction
Endothelial control of Vasodilatation
and Vasoconstriction
The endothelium, which lies between
the blood and the vascular smooth muscle,
serves as a physical barrier for vasoactive
substances that circulate in the blood. Once
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thought to be nothing more than a single layer
of cells that line blood vessels, it is now known
that the endothelium plays an active role in
controlling vascular function. In cappilaries,
which are composed of a single layer of
endothelial cells, the endothelium is active in
transporting cell nutrients and wastes. In
addition to its function in cappilary transport,
the endothelium removes vasoactive agents
such as norepinephrine from the blood, and it
produces enzymes that convert precursor
molecules to active products (e.g.,
angiotensin I to angiotensin II in lung vessels)
[2, 3, 5, 6]. One of the important functions of
the normal endothelium is to synthesize and
release factors that control vessel dilation. Of
particular importance was the discovery first
reported in early 1980s, that the intact
endothelium was able to produce a factor that
caused relaxation of vascular smooth muscle.
This factor was originally named:
Endothelium*Derived Relaxing Factor /EDRF/
and is now known to be nitric oxide (NO).
Many other cells types produce nitric oxide by
means of similar enzymes. In these tissues,
nitric oxide affords other functions, including
modulation of nerve activity in the nervous
system [3, 6]. The normal endothelium
maintains a continuous release of nitric oxide,
which is formed from L3arginine through the
action of the enzyme nitric oxide synthase.
The production of nitric oxide can be
stimulated by a variety of endothelial agonists,
including acetylcholine, bradykinin, histamine
and thrombin. Shear stress resulting from an
increase in blood flow or blood pressure also
stimulates nitric oxide production and vessel
relaxation. Nitric oxide (NO) also inhibit
platelet aggregation and secretion of platelet
contents, many of which cause
vasoconstriction. The fact that nitric oxide is
released into the vessel lumen (to inactive
platelets) and away from the lumen (to relax
smooth muscle) suggests that it protects
against both thrombosis and vasoconstriction
[3, 6]. In addition to nitric oxide, the
endothelium also produces other vasodilating
substances such as the prostaglandin,
prostacyclin, which produces vasodilatation
and inhibits platelet aggregation. It has been
suggested that the tendency to
vasoconstriction that characterizes
atherosclerotic vessels may be related to
impaired vasodilator function due to disruption
of the vessel endothelial layer. NO is a key
mediator in both the normal and pathological
control of blood pressure. The endothelium
also produces a number of vasoconstrictor
substances, including angiotensin II.,
vasoconstrictor prostaglandins, and a family
of peptides called endothelins. There are at
least three endothelins. Endothelin31 made by
human endohelial cells, is the most potent
endogeneous vasocontrictor known [3, 7].
Endothelial cells and platelet
aggregation. Thrombosis is also an important
event in any situation in which endothelial
injury and function are lost, or blood flow is
obstructed. The aggregation of platelets and
the activation of the clotting cascade are
exquisitely sensitive to alterations in the
microenvironment. Activated platelets, in turn
release factors that initiate clotting, resulting
in the formation of complex thrombus on the
vessel wall. For thrombosis to occur,
endothelial continuity must be disrupted or the
endothelial cell surface must change from an
anticoagulant to a procoagulant surface. The
most common denuding endothelial injury is
the progressive endothelial disruption of an
andvancing atherosclerotic lesion. Denuding
endothelial injury has also been described in
homocysteinemia, as a response to the
injection of radiologic contrast dyes, and in
hypoxia and endotoxemia. In addition, the
interactions of a thrombus with the underlying
subendothelium may cause a further
disturbance of endothelial integrity. The
simplest view is that subendothelial
thrombogenic molecules are covered by a
nonthrombogenic cell layer – endothelium.
The endothelium plays an active rather than a
passive role in the control of thrombosis.
Endothelial cells also synthesize plasminogen
activators, and thus may dissolve some clots
as they form. In addition, endothelial cells at
the site of thrombosis may take up vasoactive
amines released from platelets. The presence
of these antithrombotic mechanisms on the
endothelial surface has raised the intriguing
possibility that endothelial dysfunction might
lead to thrombosis in vivo [8].
Atherosclerosis. Cardiovascular
diseases (CVD) are the major causes of
mortality in persons with diabetes, and many
factors, including hypertension, contribute to
this high prevalence of CVD. Hypertension and
coagulation changes are more frequent in
patients with diabetes compared with patients
without the disease. The major cause of
insuficient coronary flow leading to a heart
attack is the presence of atherosclerosis in
these vessels. Atherosclerosis (sometimes
called „hardening of the arteries“) is disease
characterized by a thickening of the arterial
wall with large numbers of abnormal smooth3
muscle cells and deposits of cholesterol and
other substances in the portion of the vessel
wall closest to the lumen [9]. The mechanisms
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that initiate the thickening are not clear, but it
is known that cigarette smoking, high plasme
cholesterol concentration, hypertension,
diabetes, and several other factors increase
the incidence and the severity of the
atherosclerotic process. The mechanism by
which atherosclerosis reduces coronary blood
flow is quite simple: The extra muscle cells and
various deposits in the wall bulge into the
lumen of the vessel and increase resistance
to flow. This is usually progressive, often
leading ultimately to complete occlussion.
Acute coronary occlussion may occur
because of : (l) sudden formation of a blood
clot on the roughened vessel surface, (2) the
breaking off of a fragment of blood clot or fatty
deposit that then lodges downstream,
completely blocking a smaller vessel, or (3) a
profound spasm of the vesselґs smooth
muscle. If the coronary occlussion is gradual,
the heart may remain uninjurred because, over
time new accessory vessels supplying the
same area of myocardium develop [7, 10].
The question of whether regular excercise is
protective against heart attacks is still
contraversial, although more and more
circumstantial evidence favors this view.
Certainly, modest excercise programs induce
a variety of changes consistent with a
protective effect: (l) increased diameter of
coronary arteries, (2) decreased severity of
hypertension and diabetes, which are risk
factors for atheroscleroris, (3) decreased
plasma cholesterol concentration (yet another
risk factor) whith simultaneous increase in the
plasma concentration of a cholesterol3
carrying lipoprotein thought to be protective
against atherosclerosis and (4) improved
ability to dissolve clots. Finally, the results of
long3term studies that evaluated the effects
of excercise on evidence of atherosclerosis
are also suggestive of some degree of
protection. In a number of diseases,
endothelial dysfunction is associated with the
subendothelial accumulation of blood3borne
materials. For example, the accretion of lipid
beneath the endothelium in atherosclerotic
lession reflects the failure of the endothelium
to serve as an effective barrier between tissue
and plasma. Thus, a modern view of
endothelium holds that the metabolic and
endocrine functions of its cells play a critical
role in disease. The extent and severity of
atherosclerosis is increased by diabetes.
Significant atherosclerosis is rarely found in
healthy premenopausal women, but diabetes
predisposes them to its early appearance.
Thus myocardial and cerebral infarcts are
extremely common complications of diabetes.
Indeed, atherosclerotic coronary heart
disease is the major cause of death among
adults with diabetes. Platelet aggregation an
important contributory event in
atherosclerosis at sites of endothelial cell
injury, appears to be altered in the diabetics.
A partial explanation is the observation that the
synthesis of the prostaglandin thromboxane A
2
is inreased while the counterbalancing effects
of the prostacyclins are reduced. The
superimposed effects of the individualґs
genetic predisposition to vascular disease and
such risk factors as smoking and the use of
oral contraceptives are obviously also
important. Whatever the complex of
pathophysiologic abnormalities that results in
occlusive vascular disease, such disease is a
major cause of morbidity and mortality among
diabetic patients [9, 11].
Conclusions
Important functions of the normal
endothelium is to synthesize and release
factors that can control vessel dilation and
platelets activity. Endothelial dysfunctions with
lower liberation of vasodilatatory active
substances play important roles in
accelerating of many pathological changes
leading to a variety cardiovascular disorders
with vasoconstriction and in subsequent
hypertension, with platelet hyperaggregability
and coagulation abnormalities. They are very
important risk factors for life3threatening
complications such as coronary artery
diseases, atherothrombosis, heart failure and
stroke as well as risk factors of nephrological
disorders with end3stage renal disease,
diseases associated with serious
cardiovascular and renal co3morbidity.
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Резюме
ЭНДОТЕЛИЙ И ДИСФУНКЦИЯ
ЭНДОТЕЛИЯ — ПОСЛЕДСТВИЯ ДЛЯ
ЗДОРОВЬЯ И РИСК СЕРДЕЧНО3
СОСУДИСТЫХ ЗАБОЛЕВАНИЙ
Rutowski J.A.,  Novotny J., Stanciak J.
Эндотелий — однослойный пласт
плоских клеток мезенхимного происхожде3
ния, выстилающий внутреннюю поверх3
ность кровеносных и лимфатических сосу3
дов, сердечных полостей. Еще недавно
эндотелий считался простым структурным
барьером, который просто модулировал
проникновение веществ через стенку сосу3
да, обеспечивая поры соответствующего
размера. Во многом в результате прогрес3
са в технологии культивирования тканей, в
настоящее время показано, что эндотели3
альные клетки осуществляют многочислен3
ные метаболические функции.
Ключевые слова: Эндотелий, эндотели*
альные клетки, эндокринный орган, сосу*
дистая система, NO, простациклин, дис*
функция эндотелия, атеросклероз, сер*
дечно*сосудистые заболевания.
Резюме
ЕНДОТЕЛІЮ І ДИСФУНКЦІЯ
ЕНДОТЕЛІЮ 3 НАСЛІДКИ ДЛЯ
ЗДОРОВ’Я І РИЗИК СЕРЦЕВО3
СУДИННИХ ЗАХВОРЮВАНЬ
Rutowski J.A., Novotny J.,  Stanciak J.
Ендотелій 3 одношаровий пласт плос3
ких клітин мезенхимного походження, що
вистилає внутрішню поверхню кровоносних
і лімфатичних судин, серцевих порожнин.
Ще недавно ендотелій вважався простим
структурним бар’єром, який просто моду3
лював проникнення речовин через стінку
сосуду, забезпечуючи пори відповідного
розміру. Багато в чому в результаті прогре3
су в технології культивування тканин, в да3
ний час показано, що ендотеліальні кліти3
ни здійснюють численні метаболічні
функції.
Ключові слова: Ендотелій, ендотеліальні
клітини, ендокринний орган, судинна си*
стема, NO, простациклін, дисфункція ен*
дотелію, атеросклероз, серцево*судинні
захворювання.
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ОСОБЕННОСТИ УГЛЕВОДНОГО И НУКЛЕОТИДНОГО ОБМЕНОВ
ПРИ РАЗЛИЧНОЙ ЭКСПРЕССИИ СD 34 В АДЕНОКАРЦИНОМЕ
МОЛОЧНОЙ ЖЕЛЕЗЫ
Шатова О.П., Хилько Д.А., Хомутов Е.В., Зинкович И.И., Седаков И.Е.,
Скоробогатова З.М.
Донецкий национальный медицинский университет им. М.Горького
В данном исследовании изучена взаимосвязь между уровнем экспрессии СD 34 в
опухоли молочной железы и активностью ферментов обмена углеводов и нуклеотидов.
Установлена статистически значимая связь между активностью тимидинфосфорилазы в
сыворотке крови и показателем экспрессии СD 34 в аденокарциноме молочной железы.
Тимидинфосфорилаза и СD 34 участвуют в неоангиогенезе и взаимосвязаны со степе3
нью лимфогенного метастазирования.
Ключевые слова: рак молочной железы, СD 34, обмен углеводов и нуклеотидов.
